I have now re-examined this document:

It clearly does indicate both the risks of bacterial infection & to prescribe broad spectrum antibiotics as part of treatment:
"Collect blood cultures for bacteria that cause pneumonia and sepsis, ideally before antimicrobial therapy. DO NOT
delay antimicrobial therapy"
"6. Management of severe COVID-19: treatment of co-infections
Give empiric antimicrobials [broad spectrum antibiotics] to treat all likely pathogens causing SARI and sepsis as soon as possible, within 1 hour
of initial assessment for patients with sepsis."
"Empiric antibiotic treatment should be based on the clinical diagnosis (community-acquired
pneumonia, health care-associated pneumonia [if infection was acquired in health care setting] or sepsis), local epidemiology &
susceptibility data, and national treatment guidelines"
"When there is ongoing local circulation of seasonal influenza, empiric therapy with a neuraminidase inhibitor [anti-viral influenza drugs] should
be considered for the treatment for patients with influenza or at risk for severe disease."
"Empiric therapy should be de-escalated on the basis of microbiology results and clinical judgment"

THE WHO IS CALLING FOR DOCTOR'S JUDGEMENT ON WHEN TO STOP ANTIBIOTICS.

ANTIBIOTICS WERE ALWAYS PART OF THE COVID19 CURE, EVEN ACCORDING TO THE WHO.

Why is this controversial?
Therefore AZYTHROMYCIN was indeed included in the category of indicated treatments by the WHO, as it is indeed an empiric antimicrobial therapy drug.
AZYTHROMYCIN was of course considered safe by the WHO
https://t.co/sw4e7AAIXM
As are MINOCYCLINE & DOXYCYCLINE. Thread continues here: https://t.co/KEuohls1vi

More from Robin Monotti

More from Health

You May Also Like